BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12642582)

  • 1. Erythroid gene suppression by NF-kappa B.
    Liu JJ; Hou SC; Shen CK
    J Biol Chem; 2003 May; 278(21):19534-40. PubMed ID: 12642582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation of human zeta 2 globin promoter by the alpha globin regulatory element (HS-40): functional role of specific nuclear factor-DNA complexes.
    Zhang Q; Reddy PM; Yu CY; Bastiani C; Higgs D; Stamatoyannopoulos G; Papayannopoulou T; Shen CK
    Mol Cell Biol; 1993 Apr; 13(4):2298-308. PubMed ID: 8455611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic footprinting and sequencing of human beta-globin locus. Tissue specificity and cell line artifact.
    Reddy PM; Stamatoyannopoulos G; Papayannopoulou T; Shen CK
    J Biol Chem; 1994 Mar; 269(11):8287-95. PubMed ID: 8132552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter.
    Sawado T; Igarashi K; Groudine M
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10226-31. PubMed ID: 11517325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation domain of the enhancer binding protein p45NF-E2 interacts with TAFII130 and mediates long-range activation of the alpha- and beta-globin gene loci in an erythroid cell line.
    Amrolia PJ; Ramamurthy L; Saluja D; Tanese N; Jane SM; Cunningham JM
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10051-6. PubMed ID: 9294161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer.
    Kotkow KJ; Orkin SH
    Mol Cell Biol; 1995 Aug; 15(8):4640-7. PubMed ID: 7623856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein.
    Ney PA; Sorrentino BP; Lowrey CH; Nienhuis AW
    Nucleic Acids Res; 1990 Oct; 18(20):6011-7. PubMed ID: 2235483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-γ suppresses activin A/NF-E2 induction of erythroid gene expression through the NF-κB/c-Jun pathway.
    Lee WH; Chung MH; Tsai YH; Chang JL; Huang HM
    Am J Physiol Cell Physiol; 2014 Feb; 306(4):C407-14. PubMed ID: 24336657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct interaction of NF-E2 with hypersensitive site 2 of the beta-globin locus control region in living cells.
    Forsberg EC; Downs KM; Bresnick EH
    Blood; 2000 Jul; 96(1):334-9. PubMed ID: 10891470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.
    Tahara T; Sun J; Igarashi K; Taketani S
    Biochem Biophys Res Commun; 2004 Nov; 324(1):77-85. PubMed ID: 15464985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP-dependent protein kinase is necessary for increased NF-E2.DNA complex formation during erythroleukemia cell differentiation.
    Garingo AD; Suhasini M; Andrews NC; Pilz RB
    J Biol Chem; 1995 Apr; 270(16):9169-77. PubMed ID: 7721832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.
    Solomon WB; Lin CH; Palma J; Gao XY; Wu S
    J Biol Chem; 1993 Mar; 268(7):5089-96. PubMed ID: 8444885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loading of DNA-binding factors to an erythroid enhancer.
    Wen SC; Roder K; Hu KY; Rombel I; Gavva NR; Daftari P; Kuo YY; Wang C; Shen CK
    Mol Cell Biol; 2000 Mar; 20(6):1993-2003. PubMed ID: 10688646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins.
    Itoh K; Igarashi K; Hayashi N; Nishizawa M; Yamamoto M
    Mol Cell Biol; 1995 Aug; 15(8):4184-93. PubMed ID: 7623813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and functional characterization of LCR-F1: a bZIP transcription factor that activates erythroid-specific, human globin gene expression.
    Caterina JJ; Donze D; Sun CW; Ciavatta DJ; Townes TM
    Nucleic Acids Res; 1994 Jun; 22(12):2383-91. PubMed ID: 8036168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse ferritin H subunit gene. Functional analysis of the promoter and identification of an upstream regulatory element active in erythroid cells.
    Beaumont C; Seyhan A; Yachou AK; Grandchamp B; Jones R
    J Biol Chem; 1994 Aug; 269(32):20281-8. PubMed ID: 8051121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of NF-E2 activity in erythroleukemia cell differentiation.
    Nagai T; Igarashi K; Akasaka J; Furuyama K; Fujita H; Hayashi N; Yamamoto M; Sassa S
    J Biol Chem; 1998 Feb; 273(9):5358-65. PubMed ID: 9478996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: the effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer.
    Miller JL; Walsh CE; Ney PA; Samulski RJ; Nienhuis AW
    Blood; 1993 Sep; 82(6):1900-6. PubMed ID: 8400240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-E2p18/mafK is required in DMSO-induced differentiation of Friend erythroleukemia cells by enhancing NF-E2 activity.
    Francastel C; Poindessous-Jazat V; Augery-Bourget Y; Robert-Lézénès J
    Leukemia; 1997 Feb; 11(2):273-80. PubMed ID: 9009092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.